Page 32 - MemoriaCIBER-2017ENG

Programa de Biomateriales y Terapias avanzadas
Coordinator: Julio San Román del Barrio
In 2017 a national patent was extended to a PCT, and later on it was licensed to a company
Financing was obtained for the inter-CIBER NanoCrisprAlbino Therapy project intended for developing a new advanced therapy intended for treating albinism The NANOBIOCEL (CIBER-BBN) groups led by José Luis Pedraz and the group led by Lluís Montoliu (CIBERER) are collaborating in this project and it has been one of the four projects to have bene tted from aid as part of the internal CIBER call for carrying out multi-disciplinary projects between CIBER-BBN, CIBERER and CIBERES
As regards European projects, researchers Luis Fernández and Iñaki Ochoa from the GEMMUZ Group are cooperating in the new European ORCHID project, which is intended to speed up the social and economic impact of the technology known as Organ-on-Chip The BIOFORGE Group, led by José Carlos Rodríguez Cabello, develops new hydrogels for biomedical applications in the European BIOGEL consortium
The Ocular Surface Group of the IOBA-UVA, led by Margarita Calonge, has opened the rst multidisci- plinary and referential unit for OculoFacial Pain (UniDOF) in Spain; it has been one of the three Spanish teams taking part in the HOLOCORE, clinical study, with which it seeks to prove the security and e ec- tiveness of a cell therapy medication in patients with moderate to severe limbal stem cell-de ciencies due to corneal burns Dr Calonge’s team also cooperates in the projects entitled Integrated Training in Dry Eye Disease Drug Development (IT-DED3), and Drug Discovery and Delivery Network for Oncology and Eye Therapeutics (3D – NEONET), nanced by means of the European Union Marie Sklodowska-Cu- rie programme
Juan Manuel Bellón and Gemma Pascual from the Universidad de Alcalá Group have taken part in a new study intended for use of the New Zealand white rabbit as an experimental animal for several models of repair of the abdominal wall The report of this study was published in the prestigious Tissue Engi- neering journal
As regards awards and distinctions, María Vallet Regí (CIBI-UCM) was awarded the ‘Julio Peláez’ prize for Pioneers in Physical, Chemical and Mathematical Sciences, granted by the Fundación Tatiana Pérez de Guzmán el Bueno Dr Vallet was also presented as a new member of the American Institute for Medical and Biological Engineering (AIMBE), thus highlighting the extraordinary career of the Group led by her
Ángel Raya, head of the CMR[B] Group, leads the new Clinical Translational Programme for Regenerative Medicine in Catalonia (P-CMR[C]) set up in cooperation with the IDIBELL and which is located at Duran i Reynals Hospital
As regards transversal activities, the CIBER-BBN continues to be an Interested Party of the Advanced Therapies Committee (CAT) of the European Medicines Agency (EMA) and has continued relations with the Spanish Agency for Medicines and Healthcare products (AEMPS) in all aspects connected with the development of new advanced therapy products
32 CIBER ANNUAL REPORT 2017